Evidence. Protocol. Truth.

Physician-curated deep dives into the science of men's health optimization.

Monograph

Polysomnography vs Home Sleep Apnea Testing

Sleep-disordered breathing — primarily obstructive sleep apnea (OSA) — is one of the most common, most underdiagnosed, and most consequential conditions in adult medicine. Untreated moderate-to-severe OSA is associated with hypertension, atrial…

30 May 2026

Monograph

Tongkat Ali vs Fadogia Agrestis

Tongkat Ali (Eurycoma longifolia) and Fadogia agrestis are the two herbs that have dominated the men's testosterone-supplement conversation since approximately 2020. The pairing was popularized in optimization-medicine influencer content and has…

30 May 2026

Monograph

Statins vs PCSK9 Inhibitors vs Bempedoic Acid vs Inclisiran

Modern lipid management has four major pharmacological pillars: statins (the dominant first-line therapy), PCSK9 inhibitor monoclonal antibodies (evolocumab and alirocumab, the most potent LDL-lowering option), bempedoic acid (the newer non-statin…

30 May 2026

Monograph

Rapamycin vs Metformin for Longevity

Rapamycin (sirolimus) and metformin are the two off-label drugs most often discussed in the longevity optimization conversation. Both have substantial preclinical evidence for healthspan or lifespan benefit, both have been the subject of ongoing…

30 May 2026

Monograph

NMN vs NR vs Niacinamide — NAD+ Precursors

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme central to cellular energy metabolism, DNA repair, and sirtuin-mediated signaling involved in aging biology. Circulating and tissue NAD+ levels decline with age in animals and humans. Multiple…

30 May 2026

Monograph

Berberine vs Metformin

Metformin is the most-prescribed glucose-lowering medication in the world, with over six decades of clinical use, validated efficacy in type 2 diabetes, an extensive safety database, an emerging longevity literature, and a generic cash price of…

30 May 2026

Monograph

Tirzepatide vs Semaglutide vs Retatrutide

The GLP-1 receptor agonist class has revolutionized obesity medicine over the past five years, but "GLP-1" as a single category obscures three quite different products. Semaglutide (Wegovy for obesity, Ozempic for T2D) is a single GLP-1 receptor…

30 May 2026

Monograph

VO2max Testing — Methods Comparison

VO2max — maximum oxygen consumption during exhaustive exercise — is the single most predictive fitness metric for all-cause mortality across multiple longitudinal cohort studies. Companion to the existing Vanguard VO2max Maximization Protocols…

30 May 2026

Monograph

HRV Interpretation & Training Apps

Heart rate variability has become one of the most-marketed metrics in consumer wearable health tracking. The underlying physiology is real and well-characterized: variation in time between successive heartbeats reflects autonomic nervous system…

30 May 2026

Monograph

Lumen — Metabolic Flexibility Tracking

Lumen is a consumer-direct handheld device that measures CO₂ concentration in a single exhaled breath, computes the respiratory exchange ratio (RER), and reports a number indicating whether the user is metabolically in a fat-burning or…

30 May 2026

Monograph

Eight Sleep, ChiliSleep, and Temperature-Controlled Sleep Tech

Active mattress temperature control — water-circulated cooling and heating beneath a fitted topper — has emerged from a niche sleep-optimization product category into one of the most-evidenced consumer sleep interventions of the past decade. The…

30 May 2026

Monograph

Wearable Comparison — Oura vs Whoop vs Apple Watch vs Garmin

The wearable category dominant in the optimization community in 2026 reduces to four products: the Oura Ring Generation 4, the Whoop 4.0 (with the newer 5.0 sensor band launching), the Apple Watch Series 10, and the Garmin Fenix/Forerunner line.…

30 May 2026

V
Vanguard AI
Research Assistant
Feedback